SCHEMBL22848859

SCHEMBL22848859

COc1cc2nn(C3CCCCC3)cc2cc1NC(=O)c1cc(F)ccc1F

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 20/20 0.55
FLT3 P36888 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26356336 0.92 IRAK4 (0.54) IRAK4
SCHEMBL26349192 0.89 IRAK4 (0.53) IRAK4
SCHEMBL22848800 0.89 IRAK4 (0.52) IRAK4
SCHEMBL22849148 0.86 IRAK4 (0.58) IRAK4FLT3
SCHEMBL22848856 0.86 IRAK4 (0.55) IRAK4FLT3
SCHEMBL22848870 0.85 IRAK4 (0.60) IRAK4FLT3
SCHEMBL22849233 0.84 IRAK4 (0.54) IRAK4
SCHEMBL22849231 0.84 IRAK4 (0.54) IRAK4
SCHEMBL22849016 0.84 IRAK4 (0.60) IRAK4FLT3
SCHEMBL22836584 0.83 IRAK4 (0.53) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020264499-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed